---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-067689"
form_type: "8-K"
ticker: "RBOT"
cik: "0001812173"
company_name: "Vicarious Surgical Inc."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:06:34.148210+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vicarious Surgical Q2 net loss $15.2M; cash burn $10.9M, reiterates FY2024 ~$50M

## Summary
- GAAP net loss $15.2M ($2.59/sh) vs $15.3M ($3.62/sh) in Q2 2023; adjusted net loss $16.8M ($2.86/sh).
- Operating expenses $17.7M, down 17% YoY; R&D $10.9M, G&A $5.6M, S&M $1.2M.
- Cash and investments $73.2M as of June 30, 2024; Q2 2024 cash burn $10.9M.
- Reaffirmed full-year 2024 cash burn guidance of approximately $50 million.
- Partnered with LSU Health New Orleans as fifth U.S. hospital system; V1.0 integration milestone on track for fall 2024.

## SEC filing metadata
- accession: 0001213900-24-067689
- form_type: 8-K
- ticker: RBOT
- cik: 0001812173
- company_name: Vicarious Surgical Inc.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812173/000121390024067689/0001213900-24-067689-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812173/000121390024067689/ea0210959-8k_vicarious.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-067689
- JSON: https://secwatch.observer/filing/0001213900-24-067689.json
- Plain text: https://secwatch.observer/filing/0001213900-24-067689.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.